General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.

Raising CML Awareness This Month!

Novartis is joining the CML community to elevate global awareness of the disease on 9/22.

CML Awareness Information

Click here to learn more.

Featured news

Novartis acromegaly treatment recommended by CHMP for EU approval

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for a Novartis treatment that, if approved by the EU Commission, represents a potential new option for acromegaly patients...